Fundraising Fox
CITES
Venture capitalSunchales · Pre-Seed–Series A · 10 people tracked
Find your way into CITES
Sign up to see every warm intro you have to CITES
- Paths you didn't know you had: your email and LinkedIn already hold routes to the CITES team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
CITES invests in deep-tech and scientific startups, aiming to transform disruptive science into viable businesses that address major modern challenges. Operating from Argentina and the wider region, it backs founders from the earliest idea stage through Series A with capital of up to USD 3.5M, using SAFEs at early stages and equity later. Beyond money, it offers active management support, access to a global network of mentors, strategic partners and investors, and physical infrastructure including fab-labs, wet-labs and co-working/office space in Sunchales, Buenos Aires and Bariloche. Its focus spans biotech, healthtech, agtech, foodtech, medtech, robotics, AI, pharma and smart-city/logistics.
Source: firm website, verified Sep 26, 2026.
Team · 10 people
from the firm's website
What they invest in
from 4 of 21 portfolio companiesAI & Machine Learning ×3Biotech ×3Healthtech ×3Deep Tech ×2Medical Devices ×2Digital Health ×1Hardware ×1
HQs:Argentina×2United States×1
Investments · 21 tracked
founders shown can be your intro path
Ab Astra is a deep-tech company developing proprietary muon sensors and a data platform that use cosmic-ray muography to non-invasively image the density and internal structure of large subsurface structures.
AI & Machine LearningDeep TechHardwareNeuquén, AR
Germán Serrano(Founder)in
Co-investorsDraper Cygnus
Amnova Biotech develops injectable therapies derived from amniotic biomaterials to promote heart regeneration following ischemic injury.
BiotechDeep TechHealthtechMedical DevicesBuenos Aires, AR
Pilar Ferrer(CEO and Co-Founder)inMariano Berra(Co-Founder and CTO)Daniela Olea(Scientific Founder)
Co-investorsStart-Up Chile
Epiliquid develops blood-based molecular tests for cancer detection and differential diagnosis using a platform that combines AI-driven methylation biomarker discovery, patented native-DNA assay chemistry, and PCR-based readout.
AI & Machine LearningBiotechHealthtech
Co-investorsAIR Capital
ViewMind develops technology that provides objective, measurable data about brain function under cognitive stress to support clinical evaluation.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesUnited States, US
Mark Edwards(CEO & Co-founder)inGerardo Fernandez(CSO & Co-founder)in
Co-investorsVerge HealthTech FundiThink VCWealthing VC ClubZentynel Frontier InvestmentsIdealityRoads
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
ArdanBaxxis MedtechBioseekCirca TherapeuticsCloverCloverLifeCrinsuranceEolo PharmaErgo BioscienceImvalvLimay BiosciencesPeptonPhylumtechRadbioSingle Strand BiotechStradotTeramot
Frequently asked questions
- How many investments has CITES made?
- CITES has 21 tracked investments.
- What stage does CITES invest at?
- CITES invests at the Pre-Seed, Seed, Series A stages.
- What is CITES's typical check size?
- CITES typically writes checks of $3.5M.
- What sectors does CITES focus on?
- CITES focuses on AgTech, AI & Machine Learning, Biotech, Deep Tech, FoodTech, Healthtech, Impact & Social Good, Logistics & Supply Chain, Medical Devices, Robotics.
- Where is CITES located?
- CITES is headquartered in Sunchales, AR.
- Does CITES lead rounds?
- Yes, CITES leads investment rounds.
- Who does CITES co-invest with?
- CITES most often shares deals with AIR Capital, Draper Cygnus, Verge HealthTech Fund, among 7 tracked co-investors.
Media · Podcasts & interviews
featuring the teamNicolás Tognalli, managing partner de CITES
Vaca Muerta News · Nicolás Tognalli
Nicolás Tognalli, Managing Partner de CITES, en Pymes en La Red
Somos Pymes · Nicolás Tognalli
CITES | Centro de Innovación Tecnológica Empresarial y Social | Dr. Nicolás Tognalli
Meridiano Digital · Nicolás Tognalli
Nicolás Tognalli - Gerente CITES
BCR News · Nicolás Tognalli
Similar investors
Everywhere Ventures is an early-stage venture firm that writes pre-seed checks and is backed by a community of founder and operator LPs.
BDC (Business Development Bank of Canada) is a Canadian financial institution that has supported small and medium-sized businesses across all industries and stages of growth for over 80 years, providing financing and advisory services.
Tal Ventures is an Israel-based venture capital group with strong ties to the Israeli high-tech ecosystem, backing startups led by experienced founders whose technologies can make a difference.
Artesian is a deep tech and hardware venture capital investor that builds funds around specific institutional backers — governments, corporations, universities, industry bodies and super funds — to pursue both financial returns and strategic outcomes in critical industries.
Qbic is an inter-university venture capital fund that backs the transformation of technological breakthroughs from its academic and research partners into sustainable businesses.